Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 4, 2024Pediatric Blood & CancerOpen Access

Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMilica MiladinovicDRDirk ReinhardtHHHenrik Hasle

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miladinovic et al. (2024) studied this question.

synapsesocial.com/papers/68e615d9b6db6435875a875ehttps://doi.org/10.1002/pbc.31141
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1How I treat paediatric relapsed acute myeloid leukaemia2014 · 33 citations
  2. 2The Epigenetic Landscape of Acute Myeloid Leukemia2014 · 108 citations
  3. 3Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome2023 · 17 citations
  4. 4Gemtuzumab Ozogamicin Reduces Relapse Risk in <i>FLT3</i> /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group2015 · 60 citations
  5. 5Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia2016 · 1,076 citations